The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Plasma Free Amino Acid Profiling of Five Types of Cancer Patients and Its Application for Early Detection
Open accessAbstract
BACKGROUND: Recently, rapid advances have been made in metabolomics-based, easy-to-use early cancer detection methods using blood samples. Among metabolites, profiling of plasma free amino acids (PFAAs) is a promising approach because PFAAs link all organ systems and have important roles in metabolism. Furthermore, PFAA profiles are known to be influenced by specific diseases, including cancers. Therefore, the purpose of the present study was to determine the characteristics of the PFAA profiles in cancer patients and the possibility of using this information for early detection. METHODS AND FINDINGS: Plasma samples were collected from approximately 200 patients from multiple institutes, each diagnosed with one of the following five types of cancer: lung, gastric, colorectal, breast, or prostate cancer. Patients were compared to gender- and age- matched controls also used in this study. The PFAA levels were measured using high-performance liquid chromatography (HPLC)-electrospray ionization (ESI)-mass spectrometry (MS). Univariate analysis revealed significant differences in the PFAA profiles between the controls and the patients with any of the five types of cancer listed above, even those with asymptomatic early-stage disease. Furthermore, multivariate analysis clearly discriminated the cancer patients from the controls in terms of the area under the receiver-operator characteristics curve (AUC of ROC >0.75 for each cancer), regardless of cancer stage. Because this study was designed as case-control study, further investigations, including model construction and validation using cohorts with larger sample sizes, are necessary to determine the usefulness of PFAA profiling. CONCLUSIONS: These findings suggest that PFAA profiling has great potential for improving cancer screening and diagnosis and understanding disease pathogenesis. PFAA profiles can also be used to determine various disease diagnoses from a single blood sample, which involves a relatively simple plasma assay and imposes a lower physical burden on subjects when compared to existing screening methods.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The meaning and use of the area under a receiver operating characteristic (ROC) curve.
Hanley, J. A., & McNeil, B. J. (1982) · Radiology · doi:10.1148/radiology.143.1.7063747 · Cited by 21,856
TNM Classification of Malignant Tumours
(1987) · Springer eBooks · doi:10.1007/978-3-642-82982-6 · Cited by 16,049
Detection of microRNA Expression in Human Peripheral Blood Microvesicles
Hunter, M. P., Ismail, N., Zhang, X., Aguda, B. D., Lee, E. J., Yu, L., Xiao, T., Schafer, J., Lee, M.-L. T., Schmittgen, T. D., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003694 · Cited by 1,452
HMGB1 and RAGE in Inflammation and Cancer
Sims, G. P., Rowe, D. C., Rietdijk, S. T., Herbst, R., & Coyle, A. J. (2010) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132603 · Cited by 1,436 · cited 1×
“For example, the transcriptional regulatory molecule high-mobility group B1 (HMGB1) was recently shown to regulate cancer-cell tumorigenesis, expansion, and invasion [51,52,53].”
BackgroundMuller, A. J., DuHadaway, J. B., Donover, P. S., Sutanto-Ward, E., & Prendergast, G. C. (2005) · Nature Medicine · doi:10.1038/nm1196 · Cited by 1,064
Hirayama, A., Kami, K., Sugimoto, M., Sugawara, M., Toki, N., Onozuka, H., Kinoshita, T., Saito, N., Ochiai, A., Tomita, M., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4806 · Cited by 956
The effect of normalization of plasma amino acids on hepatic encephalopathy in man.
Fischer, J. E., Rosen, H. M., Ebeid, A. M., James, J. H., Keane, J. M., & Soeters, P. B. (1976) · PubMed · Cited by 580
Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer
Roth, C., Rack, B., Müller, V., Janni, W., Pantel, K., & Schwarzenbach, H. (2010) · Breast Cancer Research · doi:10.1186/bcr2766 · Cited by 430
Inhibitors of indoleamine-2,3-dioxygenase for cancer therapy: can we see the wood for the trees?
Löb, S., Königsrainer, A., Rammensee, H.-G., Opelz, G., & Terness, P. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2639 · Cited by 421
Serum Metabolite Profiling of Human Colorectal Cancer Using GC−TOFMS and UPLC−QTOFMS
Qiu, Y., Cai, G., Su, M., Chen, T., Zheng, X., Xu, Y., Ni, Y., Zhao, A., Xu, L. X., Cai, S., et al. (2009) · Journal of Proteome Research · doi:10.1021/pr9004162 · Cited by 395
Denkert, C., Budczies, J., Kind, T., Weichert, W., Tablack, P., Sehouli, J., Niesporek, S., Könsgen, D., Dietel, M., & Fiehn, O. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0755 · Cited by 378
Löb, S., Königsrainer, A., Zieker, D., Brücher, B. L. D. M., Rammensee, H.-G., Opelz, G., & Terness, P. (2009) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-008-0513-6 · Cited by 304
Early Detection of Recurrent Breast Cancer Using Metabolite Profiling
Asiago, V. M., Alvarado, L. Z., Shanaiah, N., Gowda, G. A. N., Owusu-Sarfo, K., Ballas, R. A., & Raftery, D. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1319 · Cited by 274
Plasma Amino Acid Levels in Diabetic Ketoacidosis
Felig, P., Marliss, E., Ohman, J. L., & Cahill, G. F. (1970) · Diabetes · doi:10.2337/diab.19.10.727 · Cited by 242
Urine Metabolite Analysis Offers Potential Early Diagnosis of Ovarian and Breast Cancers
Slupsky, C. M., Steed, H., Wells, T. H., Dabbs, K., Schepansky, A., Capstick, V., Faught, W., & Sawyer, M. B. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1434 · Cited by 242
Early Stage Diagnosis of Oral Cancer Using 1H NMR–Based Metabolomics
Tiziani, S., Lopes, V., & Günther, U. L. (2009) · Neoplasia · doi:10.1593/neo.81396 · Cited by 237
Plasma free amino acid profile in cancer patients
Lai, H.-S., Lee, J.-C., Lee, P.-H., Wang, S.-T., & Chen, W.-J. (2005) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2005.04.003 · Cited by 211
Noninvasive Urinary Metabonomic Diagnosis of Human Bladder Cancer
Pasikanti, K. K., Esuvaranathan, K., Ho, P. C., Mahendran, R., Kamaraj, R., Wu, Q. H., Chiong, E., & Chan, E. C. Y. (2010) · Journal of Proteome Research · doi:10.1021/pr901173v · Cited by 200
Shimbo, K., Yahashi, A., Hirayama, K., Nakazawa, M., & Miyano, H. (2009) · Analytical Chemistry · doi:10.1021/ac900470w · Cited by 176
Self-citationShimbo, K., Oonuki, T., Yahashi, A., Hirayama, K., & Miyano, H. (2009) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.4026 · Cited by 174
Self-citationNoguchi, Y., Zhang, Q., Sugimoto, T., Furuhata, Y., Sakai, R., Mori, M., Takahashi, M., & Kimura, T. (2006) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.2.513s · Cited by 164
Rocha, C., Barros, A. S., Gil, A. M., Goodfellow, B. J., Humpfer, E., Spraul, M., Carreira, I. M., Melo, J. B., Bernardo, J., Gomes, A., et al. (2009) · Journal of Proteome Research · doi:10.1021/pr9006574 · Cited by 160
Maeda, J., Higashiyama, M., Imaizumi, A., Nakayama, T., Yamamoto, H., Daimon, T., Yamakado, M., Imamura, F., & Kodama, K. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-690 · Cited by 160
Self-citationPlasma arginine concentrations are reduced in cancer patients: evidence for arginine deficiency?
Vissers, Y. L. J., Dejong, C. H. C., Luiking, Y. C., Fearon, K. C. H., MEYENFELDT, M. F. V., & Deutz, N. E. P. (2005) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/81.5.1142 · Cited by 160
Bictash, M., Ebbels, T. M., Chan, Q., Loo, R. L., Yap, I. K. S., Brown, I. J., de Iorio, M., Daviglus, M. L., Holmes, E., Stamler, J., et al. (2010) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2009.10.001 · Cited by 140
Urayama, S., Zou, W., Brooks, K., & Tolstikov, V. (2010) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.4420 · Cited by 137
Chadeau‐Hyam, M., Ebbels, T. M. D., Brown, I. J., Chan, Q. M., Stamler, J., Huang, C. C., Daviglus, M. L., Ueshima, H., Zhao, L., Holmes, E. C., et al. (2010) · Journal of Proteome Research · doi:10.1021/pr1003449 · Cited by 136
Tumor immune escape mediated by indoleamine 2,3-dioxygenase
Ζαμανάκου, Μ., Germenis, A. E., & Karanikas, V. (2007) · Immunology Letters · doi:10.1016/j.imlet.2007.06.001 · Cited by 132
Chung, H. W., Lee, S., Kim, H., Hong, D. J., Chung, J. B., Stroncek, D., & Lim, J. (2009) · Journal of Translational Medicine · doi:10.1186/1479-5876-7-38 · Cited by 123
Merging transcriptomics and metabolomics - advances in breast cancer profiling
Borgan, E., Sitter, B., Lingjærde, O. C., Johnsen, H., Lundgren, S., Bathen, T. F., Sørlie, T., Børresen‐Dale, A., & Gribbestad, I. S. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-628 · Cited by 121
Shimbo, K., Kubo, S., Harada, Y., Oonuki, T., Yokokura, T., Yoshida, H., Amao, M., Nakamura, M., Kageyama, N., Yamazaki, J., et al. (2009) · Biomedical Chromatography · doi:10.1002/bmc.1346 · Cited by 117
Self-citationDealing with death: HMGB1 as a novel target for cancer therapy.
Lotze, M. T., & DeMarco, R. (2003) · PubMed · Cited by 113
Fasting plasma amino acid levels in cancer patients
Norton, J. A., Gorschboth, C. M., WESLEY, R. A., BURT, M. E., & Brennan, M. F. (1985) · Cancer · Cited by 107
Roth, C., Kasimir‐Bauer, S., Pantel, K., & Schwarzenbach, H. (2011) · Molecular Oncology · doi:10.1016/j.molonc.2011.02.002 · Cited by 106
Metabolic abnormalities in the cancer patient
Heber, D., Byerly, L. O., & Chlebowski, R. T. (1985) · Cancer · doi:10.1002/1097-0142(19850101)55:1+<225::aid-cncr2820551304>3.0.co;2-7 · Cited by 99
Early detection of recurrent breast cancer using metabolite profiling.
Asiago, V. M., Alvarado, L. Z., Shanaiah, N., Gowda, N. G., Owusu-Sarfo, K., Ballas, R. A., & Raftery, D. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.15_suppl.1037 · Cited by 99
Blaise, B. J., Shintu, L., Elena‐Herrmann, B., Emsley, L., Dumas, M., & Toulhoat, P. (2009) · Analytical Chemistry · doi:10.1021/ac9007754 · Cited by 96
Plasma amino acid imbalance in patients with lung and breast cancer.
Cascino, A., Muscaritoli, M., Cangiano, C., Conversano, L., Laviano, A., Ariemma, S., Meguid, M. M., & Fanelli, F. R. (1995) · PubMed · Cited by 93
Plasma amino acid analysis for diagnosis and amino acid-based metabolic networks
Kimura, T., Noguchi, Y., Shikata, N., & Takahashi, M. (2008) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e3283169242 · Cited by 73
The prostate-cancer metabolome
Abate-Shen, C. T., & Shen, M. M. (2009) · Nature · doi:10.1038/457799a · Cited by 56
Amino acid metabolism in liver disease
Holm, E., Sedlaczek, O., & Grips, E. (1999) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/00075197-199901000-00009 · Cited by 51
Mechanisms and Treatment of Anorexia in End-Stage Renal Disease Patients on Hemodialysis
Bossola, M., Tazza, L., & Luciani, G. (2009) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2008.10.003 · Cited by 47
Nevedomskaya, E., Ramautar, R., Derks, R. J. E., Westbroek, I., Zondag, G. C. M., van der Pluijm, I., Deelder, A. M., & Mayboroda, O. A. (2010) · Journal of Proteome Research · doi:10.1021/pr100634d · Cited by 45
Okamoto, N., Miyagi, Y., Chiba, A., Akaike, M., Shiozawa, M., Imaizumi, A., Yamamoto, H., Toshihiko, Yamakado, M., & Tochikubo, O. (2009) · doi:10.5897/ijmms.9000074 · Cited by 38
Self-citationRubtsov, D. V., Waterman, C. L., Currie, R. A., Waterfield, C. J., Salazar, J. D., WRIGHT, J. A., & Griffin, J. L. (2010) · Analytical Chemistry · doi:10.1021/ac100344m · Cited by 27
Cited by
Metabolomics in cancer research and emerging applications in clinical oncology
Schmidt, D. R., Patel, R., Kirsch, D. G., Lewis, C. A., Vander Heiden, M. G., & Locasale, J. W. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21670 · Cited by 648
A Novel Serum Metabolomics-Based Diagnostic Approach for Colorectal Cancer
Nishiumi, S., Kobayashi, T., Ikeda, A., Yoshie, T., Kibi, M., Izumi, Y., Okuno, T., Hayashi, N., Kawano, S., Takenawa, T., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040459 · Cited by 262
(2020) · PubMed Central · Cited by 12
Metadata
- Authors
- Miyagi, Y., Higashiyama, M., Gochi, A., Akaike, M., Ishikawa, T., Miura, T., Saruki, N., Bando, E., Kimura, H., Imamura, F., Moriyama, M., Ikeda, I., Chiba, A., Oshita, F., Imaizumi, A., Yamamoto, H., Miyano, H., Horimoto, K., Tochikubo, O., Mitsushima, T., Yamakado, M., & Okamoto, N.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2011-09-07
- Volume
- 6
- Issue
- 9
- Pages
- e24143
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2039670227
- Cited by
- 435
- References
- 45
- FWCI
- 8.11
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.